Clinical Trial Update: MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC [NA]

View source ↗

Summary

This clinical trial compares MRI screening to symptom-directed surveillance for brain metastases in patients with triple-negative or HER2-positive metastatic br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Breast Neoplasm, Brain Metastases | NA | Status: ACTIVE_NOT_RECRUITING